Key Metrics
CiteScore 

3.3
H-Index 

51
Impact Factor 

< 5
SJR 

Q3Oncology

SNIP 

0.86
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Gastrointestinal Oncology
Journal of Gastrointestinal Oncology Journal Specifications
| Overview | |
| Publisher | AME PUBLISHING COMPANY |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Gastrointestinal Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Gastrointestinal Oncology
Clearing the bar: adding anti-VEGF therapy to chemoimmunotherapy for biliary tract cancer
- 1 Apr 2026
- Journal of Gastrointestinal Oncology
Sarcopenia in esophageal cancer: from passive prognostic marker to active treatment target
- 1 Apr 2026
- Journal of Gastrointestinal Oncology
Journal of Gastrointestinal Oncology
- 23 Mar 2026
- Journal of Gastrointestinal Oncology
DAWN trial: a prospective, multicenter, single-arm phase II study of neoadjuvant disitamab vedotin (RC48) in combination with adebrelimab, apatinib, and S-1 for locally advanced HER2-positive gastric cancer
- 12 Feb 2026
- Journal of Gastrointestinal Oncology
The EZH2-NEAT1 epigenetic axis promotes cuproptosis sensitivity and modulates cancer cell migration in colorectal cancer
- 12 Feb 2026
- Journal of Gastrointestinal Oncology
Development and internal validation of a predictive nomogram for early postoperative bacterial infections following liver transplantation in patients with hepatocellular carcinoma
- 12 Feb 2026
- Journal of Gastrointestinal Oncology
Clearing the bar: adding anti-VEGF therapy to chemoimmunotherapy for biliary tract cancer
- 1 Apr 2026
- Journal of Gastrointestinal Oncology
Sarcopenia in esophageal cancer: from passive prognostic marker to active treatment target
- 1 Apr 2026
- Journal of Gastrointestinal Oncology
Journal of Gastrointestinal Oncology
- 23 Mar 2026
- Journal of Gastrointestinal Oncology
DAWN trial: a prospective, multicenter, single-arm phase II study of neoadjuvant disitamab vedotin (RC48) in combination with adebrelimab, apatinib, and S-1 for locally advanced HER2-positive gastric cancer
- 12 Feb 2026
- Journal of Gastrointestinal Oncology
The EZH2-NEAT1 epigenetic axis promotes cuproptosis sensitivity and modulates cancer cell migration in colorectal cancer
- 12 Feb 2026
- Journal of Gastrointestinal Oncology
Development and internal validation of a predictive nomogram for early postoperative bacterial infections following liver transplantation in patients with hepatocellular carcinoma
- 12 Feb 2026
- Journal of Gastrointestinal Oncology